Correlation Between Metacrine and Instil Bio
Can any of the company-specific risk be diversified away by investing in both Metacrine and Instil Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Metacrine and Instil Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Metacrine and Instil Bio, you can compare the effects of market volatilities on Metacrine and Instil Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Metacrine with a short position of Instil Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Metacrine and Instil Bio.
Diversification Opportunities for Metacrine and Instil Bio
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Metacrine and Instil is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Metacrine and Instil Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instil Bio and Metacrine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Metacrine are associated (or correlated) with Instil Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instil Bio has no effect on the direction of Metacrine i.e., Metacrine and Instil Bio go up and down completely randomly.
Pair Corralation between Metacrine and Instil Bio
If you would invest (100.00) in Metacrine on December 22, 2024 and sell it today you would earn a total of 100.00 from holding Metacrine or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Metacrine vs. Instil Bio
Performance |
Timeline |
Metacrine |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Instil Bio |
Metacrine and Instil Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Metacrine and Instil Bio
The main advantage of trading using opposite Metacrine and Instil Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Metacrine position performs unexpectedly, Instil Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instil Bio will offset losses from the drop in Instil Bio's long position.Metacrine vs. Protara Therapeutics | Metacrine vs. CytomX Therapeutics | Metacrine vs. Assembly Biosciences | Metacrine vs. Instil Bio |
Instil Bio vs. Assembly Biosciences | Instil Bio vs. Nuvation Bio | Instil Bio vs. Achilles Therapeutics PLC | Instil Bio vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |